119 related articles for article (PubMed ID: 5723963)
21. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP
Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591
[TBL] [Abstract][Full Text] [Related]
23. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
[TBL] [Abstract][Full Text] [Related]
24. Tum- variants and the detection of tumor-specific transplantation antigens on spontaneous mouse tumors.
Boon T; van Pel A; Uyttenhove C; Marchand M; Lambotte P
Behring Inst Mitt; 1984 May; (74):209-13. PubMed ID: 6332616
[No Abstract] [Full Text] [Related]
25. Transplantation of primary plasma cell tumor without 2,6,10,14- tetramethylpentadecane (pristane) treatment of the hosts.
Platica M; Bojko C; Hollander VP
Cancer Res; 1980 Mar; 40(3):579-81. PubMed ID: 7471077
[TBL] [Abstract][Full Text] [Related]
26. Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts.
Fodstad O; Breistøl K; Pettit GR; Shoemaker RH; Boyd MR
J Exp Ther Oncol; 1996 Mar; 1(2):119-25. PubMed ID: 9414395
[TBL] [Abstract][Full Text] [Related]
27. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
Hengst JC; Mokyr MB; Dray S
Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
[No Abstract] [Full Text] [Related]
28. CFU-C yields from the haemopoietic tissues of normal and leukaemic RFM mice.
Gordon MY; Coggle JE
Cell Tissue Kinet; 1974 Jan; 7(1):61-8. PubMed ID: 4520988
[No Abstract] [Full Text] [Related]
29. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
[TBL] [Abstract][Full Text] [Related]
30. The extraction of intracisternal A-particles from a mouse plasma-cell tumor.
Kuff EL; Wivel NA; Lueders KK
Cancer Res; 1968 Oct; 28(10):2137-48. PubMed ID: 5696942
[No Abstract] [Full Text] [Related]
31. [Bone marrow suppressors of MIF production in tumor growth].
Koval'chuk LV; Sidorovich IG; Gankovskaia LV; Vlasov AA; Sokolova EV
Dokl Akad Nauk SSSR; 1982; 266(2):497-9. PubMed ID: 6216086
[No Abstract] [Full Text] [Related]
32. Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.
Li W; Hyun T; Heller M; Yam A; Flechner L; Pierce JH; Rudikoff S
Cancer Res; 2000 Jul; 60(14):3909-15. PubMed ID: 10919668
[TBL] [Abstract][Full Text] [Related]
33. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
[TBL] [Abstract][Full Text] [Related]
34. The regulation of hemopoietic cell development by the stromal cell environment and diffusible regulatory molecules.
Dexter TM; Simmons P; Purnell RA; Spooncer E; Schofield R
Prog Clin Biol Res; 1984; 148():13-33. PubMed ID: 6379657
[No Abstract] [Full Text] [Related]
35. Development and characterization of a cyclophosphamide-resistant mouse plasmacytoma cell line.
Frondoza CG; Trivedi SM; Humphrey RL
Cancer Treat Rep; 1982 Jul; 66(7):1535-44. PubMed ID: 7093969
[TBL] [Abstract][Full Text] [Related]
36. Effect of a zinc-deficient diet on the growth of an IgM-secreting plasmacytoma (TEPC-183).
Fenton MR; Burke JP; Tursi FD; Arena FP
J Natl Cancer Inst; 1980 Dec; 65(6):1271-2. PubMed ID: 6933272
[TBL] [Abstract][Full Text] [Related]
37. ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
Linden M; Kirchhof N; Kvitrud M; Van Ness B
Leuk Res; 2005 Apr; 29(4):435-44. PubMed ID: 15725478
[TBL] [Abstract][Full Text] [Related]
38. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy for malignant tumors using combination of allogeneic intra-bone marrow-bone marrow transplantation, donor lymphocyte infusion and dendritic cells.
Mukaide H; Adachi Y; Koike-Kiriyama N; Suzuki Y; Minamino K; Iwasaki M; Tsuda M; Nakano K; Koike Y; Shigematsu A; Kamiyama Y; Ikehara S
Int J Oncol; 2007 Jun; 30(6):1309-15. PubMed ID: 17487350
[TBL] [Abstract][Full Text] [Related]
40. [Virus synthesis in transplantable plasma cell tumor of mice].
Fasske E; Fetting R; Themann H; Kleine-Borchmann B
Verh Dtsch Ges Pathol; 1978; 62():497. PubMed ID: 746942
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
